MétaCan
Menu
Back to cohort
Record W2791566302 · doi:10.1093/ecco-jcc/jjx180.660

P533 Correlation of endoscopic and clinical endpoints during induction therapy in patients with moderate-to-severe Crohn’s disease: Analysis from CELEST study

2018· article· en· W2791566302 on OpenAlexaff
William J. Sandborn, B. Feagan, James D. Lewis, Silvio Danese, Walter Reinisch, David T. Rubin, Wen Zhou, Fabio Cataldi, Qing Zhou, S Goteti, Ana P. Lacerda

Bibliographic record

VenueJournal of Crohn s and Colitis · 2018
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsRobarts Clinical Trials
Fundersnot available
KeywordsMedicineInternal medicineCrohn's diseasePlaceboClinical trialGastroenterologyColonoscopyClinical endpointAbdominal painDiseaseSurgeryPathology

Abstract

fetched live from OpenAlex

The ultimate treatment goal in Crohn’s disease (CD) is to achieve remission based on clinical, endoscopic, and biological parameters. Recently, clinical trials evaluating new compounds aim at clinical and endoscopic improvements as co-primary endpoints. The relationships between clinical symptoms and endoscopic disease severity have not been established. This analysis reports correlation of endoscopic remission and response with clinical outcomes in the CELEST study.1 A total of 220 adult patients, mean ± SD age of 40.7 ± 12.9 years, CD duration of 13.2 ± 10.0 years, a CD Activity Index (CDAI) 302.8 ± 63.4, average daily liquid/very soft stool frequency (SF) 6.3 ± 3.3, average daily abdominal pain score (AP) 1.8 ± 0.5 and Simplified Endoscopic Score for CD (SES-CD) 15.0 ± 8.4 at baseline (BL), were randomised to double-blind induction therapy with placebo (PBO) or UPA 3, 6, 12, 24 mg twice daily (BID) or 24 mg once daily (QD) for 16 weeks. Follow-up ileocolonoscopy was performed at either Week 12 or 16, per randomised schedule. Correlation of CDAI <150, modified clinical remission, enhanced clinical response (all defined in Table), SF ≤2.8 and AP not worse than BL, and AP ≤1.0 and SF not worse than BL at Week 16 with endoscopic remission and endoscopic response (both defined in Table) at Week 12 of 16 were assessed in all randomised patients who had data at these visits using polychoric correlation. P-values were from Wald test. Correlation coefficients between clinical and endoscopic endpoints are shown in the table. Overall, fair to high statistically significant correlations between endoscopic remission and response at Week 12 of 16 and clinical outcomes at Week 16 were observed. Improvements in the individual CD-symptoms of SF or AP had weaker correlation with endoscopic remission. The strongest correlation was observed between AP ≤1.0 and SF not worse than BL and endoscopic response (ρ = 0.61). Correlation of clinical endpoints at Week 16 and endoscopic endpoints at Week 12 of 16a. Overall, clinical endpoints in CELEST correlated more strongly with endoscopic response than with endoscopic remission over a 16-week induction treatment period. Clinical remission (based on stool frequency and abdominal pain), and endoscopic response may be the most appropriate co-primary endpoints for short-term induction studies. 1. Sandborn WJ, et al. 2017;152(Suppl. 1):S1308–9.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.017

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.006
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.258
Teacher spread0.250 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Crohn s and ColitisSame topicInflammatory Bowel DiseaseFrench-language works237,207